Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Kura Oncology (KURA) Invested Capital (2024 - 2025)

Historic Invested Capital for Kura Oncology (KURA) over the last 2 years, with Q3 2025 value amounting to $246.9 million.

  • Kura Oncology's Invested Capital fell 4197.72% to $246.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $246.9 million, marking a year-over-year decrease of 4197.72%. This contributed to the annual value of $416.2 million for FY2024, which is N/A changed from last year.
  • According to the latest figures from Q3 2025, Kura Oncology's Invested Capital is $246.9 million, which was down 4197.72% from $308.6 million recorded in Q2 2025.
  • Over the past 5 years, Kura Oncology's Invested Capital peaked at $505.1 million during Q1 2024, and registered a low of $246.9 million during Q3 2025.